検索結果一覧

一般口演 / Oral Session

【E】一般口演 9 (Oral Session 9) :CML:Basic Research 1
 
日程
2013年10月11日(金)
時間
09:30 - 10:30
会場
第7会場 / Room No.7 (ロイトン札幌 2F リージェント)
座長・司会
木村 晋也 (Shinya Kimura):1
1:Blood and Lung and Tumor Institute, Saga University, Japan

前へ戻る


Targeting the hedgehog signaling pathway limits the self-renewal of BCR-ABL1 positive leukemia cells

演題番号 : OS-1-41

田内 哲三 (Tetsuzo Tauchi):1、片桐 誠一朗 (Seiichiro Katagiri):1、岡部 聖一 (Seiichi Okabe):1、南 陽介 (Yosuke Minami):2、直江 知樹 (Tomoki Naoe):3、大屋敷 一馬 (Kazuma Ohyashiki):1

1:1st Dept. Int. Med., Tokyo Medical Univ., Japan、2:Dept. Hematol. Oncol., Kobe Univ., Japan、3:Dept. of Hematol. Oncol., Nagoya Univ., Japan

Targeting the hedgehog signaling pathway limits the self-renewal of BCR-ABL1 positive leukemia cells

Influence of ABCB1, ABCG2 and ABCC2 haplotype in mediating imatinib resistance among CML patients

演題番号 : OS-1-42

Anthony Z.L. Au:1、Ravindran Ankathil:1、Sim A Goh:2、Fadilah S.A Wahid:3、Alan Teh:4、Aziz A. Baba:5

1:Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia、2:Dept of Medicine, Hospital Pulau Pinang, Malaysia、3:Cell Therapy Centre, UKM Medical Centre (UKMMC), Universiti Kebangsaan Malaysia, Malaysia、4:Dept of Hematology, Sime Darby Medical Center Subang Jaya, Selangor, Malaysia、5:Dept of Internal Medicine and Clinical Hematology, Universiti Sains Malaysia, Malaysia

Influence of ABCB1, ABCG2 and ABCC2 haplotype in mediating imatinib resistance among CML patients

Application of COLD-PCR for improved detection of BCR-ABL1 TKI resistance mutations

演題番号 : OS-1-43

Wenjun Tian (田 文君):1、Hui Sun:1、Qian Wang:1、Zhifen Zhang:1、Huanling Wu:1、Yuantang Li:1、Hongxing Liu (刘 红星):2、Yongjin Chen:1

1:Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong University, China、2:Lu Daopei Hematology & Oncology Center, Yanda International Hospital, China

Application of COLD-PCR for improved detection of BCR-ABL1 TKI resistance mutations

Activity of imatinib and Jak kinase inhibitor: A potential treatment for Ph-positive leukemia cells

演題番号 : OS-1-44

岡部 聖一 (Seiichi Okabe):1、田内 哲三 (Tetsuzo Tauchi):1、片桐 誠一朗 (Seiichiro Katagiri):1、田中 裕子 (Yuko Tanaka):1、大屋敷 一馬 (Kazuma Ohyashiki):1

1:First Department of Internal Medicine, Tokyo Medical University, Japan

Activity of imatinib and Jak kinase inhibitor: A potential treatment for Ph-positive leukemia cells

Initial occupancy of leukemic stem cell correlates with prognostic factor in CML patients

演題番号 : OS-1-45

宮脇 恒太 (Kohta Miyawaki):1、岩崎 浩己 (Hiromi Iwasaki):2、赤司 浩一 (Koichi Akashi):1

1:Dept of Medicine and Biosystemic Science, Kyushu University、2:Center for Cellular and Molecular Medicine, Kyushu University Hospital

Initial occupancy of leukemic stem cell correlates with prognostic factor in CML patients